Pure Global
NCT06063629

Roles of Prophylactic Subcutaneous Drain in Preventing Surgical Site Infection in Surgical Wound After Abdominal Surgery

Roles of Prophylactic Subcutaneous Drain in Preventing Surgical Site Infection in Abdominal Surgery Wound Class III and IV
Queen Savang Vadhana Memorial Hospital, Thailand·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Site Infection
Drug/Device/Intervention
Subcutaneous drain
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Queen Savang Vadhana Memorial Hospital, Thailand
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Feb 01, 2025
Enrollment
180 participants
Primary outcome

Rate of Surgical Site Infection (SSI),Rate of Surgical Site Infection (SSI),Rate of Surgical Site Infection (SSI),Rate of Surgical Site Infection (SSI),Rate of Surgical Site Infection (SSI)

Summary

Surgical site infections (SSI) pose a common challenge in the field of surgery. Current
 evidence and literature do not provide clear consensus whether the use of subcutaneous
 drainage will help reduce the incidence of SSI in patients who underwent abdominal surgery,
 especially in wounds that are categorized as contaminated (class 3) or dirty/infected (class
 4).
 
 The objective of this clinical study is to compare the rate of surgical site infection in
 contaminated and dirty/infected surgical wounds among patients whose wounds are inserted with
 subcutaneous drainage and patients who are not inserted with subcutaneous drainage.

ICD-10 classifications
Infection following a procedure, not elsewhere classifiedBacterial infection of unspecified siteOther bacterial infections of unspecified siteInfection of obstetric surgical woundOther specified local infections of skin and subcutaneous tissue
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06063629
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06063629 through Pure Global AI's free database. This phase not specified trial is sponsored by Queen Savang Vadhana Memorial Hospital, Thailand and is currently Not yet recruiting. The study focuses on Surgical Site Infection. Target enrollment is 180 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.